336 related articles for article (PubMed ID: 12481004)
1. Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases.
Hoang MP; Murakata LA; Katabi N; Henson DE; Albores-Saavedra J
Mod Pathol; 2002 Dec; 15(12):1251-8. PubMed ID: 12481004
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts.
Albores-Saavedra J; Murakata L; Krueger JE; Henson DE
Cancer; 2000 Aug; 89(3):508-15. PubMed ID: 10931449
[TBL] [Abstract][Full Text] [Related]
3. Intraductal tubular neoplasms of the bile ducts.
Katabi N; Torres J; Klimstra DS
Am J Surg Pathol; 2012 Nov; 36(11):1647-55. PubMed ID: 23073323
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive papillary carcinoma of the extrahepatic bile ducts.
Fatima S; Ahmad Z; Qureshi A; Minhas K; Pal I
J Coll Physicians Surg Pak; 2008 Oct; 18(10):649-51. PubMed ID: 18940127
[TBL] [Abstract][Full Text] [Related]
5. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.
Chuang SC; Lee KT; Tsai KB; Sheen PC; Nagai E; Mizumoto K; Tanaka M
World J Surg; 2004 Oct; 28(10):995-1000. PubMed ID: 15573254
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
Sasaki M; Sato Y
Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
[TBL] [Abstract][Full Text] [Related]
8. Invasive micropapillary carcinoma of the extrahepatic bile duct and its malignant potential.
Yoshizawa T; Toyoki Y; Hirai H; Haga T; Toba T; Sakuraba S; Okano K; Wu Y; Seino H; Morohashi S; Hakamada K; Kijima H
Oncol Rep; 2014 Oct; 32(4):1355-61. PubMed ID: 25109922
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct.
Tascilar M; Offerhaus GJ; Altink R; Argani P; Sohn TA; Yeo CJ; Cameron JL; Goggins M; Hruban RH; Wilentz RE
Am J Clin Pathol; 2001 Dec; 116(6):831-7. PubMed ID: 11764071
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
[TBL] [Abstract][Full Text] [Related]
11. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis.
Katabi N; Albores-Saavedra J
Am J Surg Pathol; 2003 Mar; 27(3):349-55. PubMed ID: 12604891
[TBL] [Abstract][Full Text] [Related]
12. Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases.
Maitra A; Krueger JE; Tascilar M; Offerhaus GJ; Angeles-Angeles A; Klimstra DS; Hruban RH; Albores-Saavedra J
Am J Surg Pathol; 2000 Nov; 24(11):1501-10. PubMed ID: 11075851
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma with pyloric gland phenotype of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of extrahepatic bile duct carcinoma.
Albores-Saavedra J; Chablé-Montero F; Méndez-Sánchez N; Mercado MÁ; Vilatoba-Chapa M; Henson DE
Hum Pathol; 2012 Dec; 43(12):2292-8. PubMed ID: 22795356
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
Teh M; Wee A; Raju GC
Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
[TBL] [Abstract][Full Text] [Related]
15. Clear cell carcinomas of the gallbladder and extrahepatic bile ducts.
Vardaman C; Albores-Saavedra J
Am J Surg Pathol; 1995 Jan; 19(1):91-9. PubMed ID: 7802141
[TBL] [Abstract][Full Text] [Related]
16. Papillary carcinomas of the gallbladder: analysis of noninvasive and invasive types.
Albores-Saavedra J; Tuck M; McLaren BK; Carrick KS; Henson DE
Arch Pathol Lab Med; 2005 Jul; 129(7):905-9. PubMed ID: 15974814
[TBL] [Abstract][Full Text] [Related]
17. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
[TBL] [Abstract][Full Text] [Related]
18. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
[TBL] [Abstract][Full Text] [Related]
20. Intraductal oncocytic papillary neoplasm of the bile duct: clinicopathologic and immunohistochemical characteristics of 6 cases.
Tanaka M; Fukushima N; Noda N; Shibahara J; Kokudo N; Fukayama M
Hum Pathol; 2009 Nov; 40(11):1543-52. PubMed ID: 19540556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
